Clinical trial
Use of Continuous Glucose Monitors in Children and Adolescents With Obesity
Recruiting now · Not applicable · 1 countries · Registry ID NCT06254768
Recruiting nowNot applicableInterventional
What this study is about
To study if continuous glucose monitors are feasible for use in children and adolescents with obesity.
A promising-looking record is not the same as confirmed eligibility. The study team must review the full criteria and current recruitment status.
Basic eligibility
Age10 Years to 21 Years
SexAll
Healthy volunteersAccepted
ConditionPediatric Obesity
Full registry criteria
Inclusion Criteria: * Age 10-21 years BMI \>95th percentile Exclusion Criteria: * Previous diagnosis of Prader Willi Syndrome or hypothalamic obesity * Intellectual disability * Previous or planned bariatric surgery * Hemoglobin A1c \>6.5 % * Current use of medication that impacts weight
Treatments and study arms
Continuous glucose monitor
Device
its a device used to measure glucose from interstitial fluids and provides feedback regarding the same every 5 minutes.
Primary outcomes
Feasibility of continuous glucose monitor(CGM) use in children and adolescents with obesity6 weeks
Investigator will measure this outcome using recruitment rate achieved each month for the duration of the study period as the number of participants screened per month over the number of participants consented.
Study locations
1 locations were listed when this page was built. The first 40 are shown.
Pediatric Endocrinology Division, University of California🇺🇸 Los Angeles, California, United States
Sri Nikhita ChimatapuContact